Actively Recruiting
Comparative Efficacy Of Intraductal Antibiotic During ERCP In Acute Cholangitis
Led by National University of Malaysia · Updated on 2026-02-12
172
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Does intraductal administration of antibiotics during endoscopic retrograde cholangiopancreatography (ERCP), in addition to standard systemic antibiotic therapy, improve clinical outcomes in patients with acute cholangitis compared with standard systemic antibiotic therapy alone?
CONDITIONS
Official Title
Comparative Efficacy Of Intraductal Antibiotic During ERCP In Acute Cholangitis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with mild or moderate acute cholangitis based on TG 18 criteria
- Planned to undergo ERCP within 48 hours
- Age 18 years or older
You will not qualify if you...
- Severe acute cholangitis
- History of antibiotic hypersensitivity
- Receiving cancer chemotherapy, steroids, or immunosuppressive agents
- Presence of other infections
- Recent biliary interventions such as percutaneous transhepatic biliary drainage within the last 3 months
- Known or suspected perforated tympanic membrane
- Diagnosis of myasthenia gravis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hospital Canselor Tuanku Muhriz UKM
Cheras, Kuala Lumpur, Malaysia, 56000
Actively Recruiting
Research Team
T
Tiew Toot Chaw
CONTACT
A
Azlanudin Azman
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here